Inactive Instrument

Forest Laboratories, Inc. Share Price

Stocks

End-of-day quote NYSE
- ^USD	-

06/14/06	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/14/06	Actavis : M&A frenzy in healthcare sector	RE

06/14/06	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/14/06	Actavis : M&A frenzy in healthcare sector	RE
14/14/14	Actavis : Investors support deals spree, happy to see U.S. companies buy growth	RE
11/14/11	Icahn backs down from demand that eBay spin off PayPal	RE
21/14/21	Suntory Beverage & Food Ltd : Goldman Sachs misses out on WhatsApp, 2014's top deals so far	RE
19/14/19	Icahn says Actavis-Forest deal validates shareholder activism	RE
19/14/19	Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/14/18	Actavis PLC : Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/14/18	Actavis PLC : Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ	RE
09/14/09	S&P 500 ends flat in wake of Fed minutes	RE
08/14/08	Forest Laboratories, Inc. : Forest Labs to buy Aptalis from TPG for $2.9 billion	RE
08/14/08	Evercore Partners Inc. : Forest Labs nears $3 billion deal for Aptalis - source	RE
24/13/24	Elan Corporation, plc : Exclusive - TPG-backed Aptalis Pharma hires banks for an IPO: sources	RE

01/14/01	Forest Laboratories : Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest	BU
30/14/30	Forest Laboratories : Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results	BU
24/14/24	Forest Laboratories : Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD)	BU
23/14/23	Forest Laboratories : Actavis and Forest Laboratories Announce Appointment of C. David Nicholson, PhD to lead Actavis Global Brands Research and Development	BU
21/14/21	Forest Laboratories : to Present Cariprazine Data at the International College of Neuropsychopharmacology World Congress	BU

17/16/17	Devisen: Euro fällt zum USD weiter - Hinweise auf US-Zinserhöhung belasten
28/14/28	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue
28/14/28	Wall Street ouvre en hausse, les pharmaceutiques en vue
28/14/28	Actavis : Forest Laboratories achète Furiex pour 1,46 milliard de dollars
28/14/28	Forest Laboratories : Pharmacie-Forest achète Furiex pour $1,46 milliard

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.01%	-2.47%	+57.79%	+108.23%	1,03400Cr
JOHNSON & JOHNSON	+1.48%	+1.93%	+54.56%	+71.49%	65TCr
ABBVIE INC.	+0.67%	-0.45%	+23.50%	+76.60%	46TCr
ROCHE HOLDING AG	+0.49%	-5.19%	+33.28%	+34.59%	34TCr
NOVARTIS AG	+0.27%	+3.26%	+29.76%	+46.97%	31TCr
ASTRAZENECA PLC	+0.12%	-2.11%	+0.60%	+11.93%	25TCr
AMGEN INC.	+1.08%	+0.57%	+54.34%	+72.51%	24TCr
NOVO NORDISK A/S	+2.64%	-1.08%	-15.85%	-53.64%	20TCr
GILEAD SCIENCES, INC.	-0.21%	+1.03%	+32.74%	+95.19%	19TCr
Average	+0.73%	-1.42%	+30.08%	+51.54%	40.8TCr
Weighted average by Cap.	+0.63%	-1.31%	+38.85%	+67.31%

Employees

Sector